Analyst Ratings for Inspire Medical Systems (INSP)
INSP Rating Summary
INSP Price Target Summary
- Highest: $285.00 (RBC Capital)
- Lowest: $159.00 (Leerink Partners)
- Average: $242.71
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$242.71 (+5.9%)
* Over Last 12-Mos
Rating Score: 7 / 10
Percentile Rank: 75%
Avg. $ Target:
$242.71 (+5.9%)
* Over Last 12-Mos
Rating Score: 7 / 10
Percentile Rank: 75%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/19/2024 | RBC Capital | Shagun Singh | New Coverage | Outperform (N/A) |
285.00 (N/A) |
243.51 (229.22) |
-5.87% | Details |
| 3/19/2024 | Morgan Stanley | Kallum Titchmarsh | New Coverage | Overweight (N/A) |
250.00 (N/A) |
199.23 (229.22) |
15.05% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
